Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Waternaux

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Psychiatry Research|February 1, 1993
Clozapine response and plasma catecholamines and their metabolitesA I Green, M Y Alam, J T Sobieraj, et al.
The American Journal of Psychiatry|April 1, 1997
Medication and psychotherapy in the treatment of bulimia nervosaB T Walsh, G T Wilson, K L Loeb, et al.
Schizophrenia Research|February 7, 1997
Thought disorder in adolescent-onset schizophreniaD Makowski, C Waternaux, C M Lajonchere, et al.
Journal of Clinical Psychopharmacology|December 1, 1991
Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressantsJ J Mooney, A F Schatzberg, J O Cole, et al.
Schizophrenia Research|June 1, 1993
Haloperidol response and plasma catecholamines and their metabolitesA I Green, M Y Alam, R A Boshes, et al.
The American Journal of Psychiatry|December 1, 1994
A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patientsL B Inderbitzin, R R Lewine, G Scheller-Gilkey, et al.
Archives of General Psychiatry|September 1, 1993
Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program datasetR D Gibbons, D Hedeker, I Elkin, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Psychiatry Research|February 1, 1993
Clozapine response and plasma catecholamines and their metabolitesA I Green, M Y Alam, J T Sobieraj, et al.
The American Journal of Psychiatry|April 1, 1997
Medication and psychotherapy in the treatment of bulimia nervosaB T Walsh, G T Wilson, K L Loeb, et al.
Schizophrenia Research|February 7, 1997
Thought disorder in adolescent-onset schizophreniaD Makowski, C Waternaux, C M Lajonchere, et al.
Journal of Clinical Psychopharmacology|December 1, 1991
Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressantsJ J Mooney, A F Schatzberg, J O Cole, et al.
Schizophrenia Research|June 1, 1993
Haloperidol response and plasma catecholamines and their metabolitesA I Green, M Y Alam, R A Boshes, et al.
The American Journal of Psychiatry|December 1, 1994
A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patientsL B Inderbitzin, R R Lewine, G Scheller-Gilkey, et al.
Archives of General Psychiatry|September 1, 1993
Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program datasetR D Gibbons, D Hedeker, I Elkin, et al.
Pageof 5